tenk.fyi

Q/C TECHNOLOGIES, INC.

QCLSNasdaq· In Vitro & In Vivo Diagnostic Substances

Price History

Revenue

-

Net Income

-$11.6M

50.2% YoY

EPS

$-8.66

99.2% YoY

Cash

$986,996

470.0% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.

Upgrade to Pro